6U22
Crystal structure of SFTI-triazole inhibitor in complex with beta-trypsin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2019-06-27 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.953730 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 62.386, 63.412, 69.517 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.462 - 1.420 |
R-factor | 0.1571 |
Rwork | 0.156 |
R-free | 0.17430 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1sfi |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHENIX |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.850 | 1.440 |
High resolution limit [Å] | 1.420 | 1.420 |
Rmerge | 0.068 | 0.371 |
Number of reflections | 52571 | 2321 |
<I/σ(I)> | 18.2 | |
Completeness [%] | 99.5 | |
Redundancy | 13.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8.5 | 277 | Precipitant: PEG4000 (25%-35% w/v), TrisBase (0.1 M, 8.5-9.5 pH) and NH4Ac (0.26 M). Protein solution: 22 mg/mL in Tris.HCl (0.1 M, pH 8.0) with CaCl2 (10 mM) |